Science Translational Medicine

Science Translational Medicine is a weekly peer-reviewed journal launched in October 2009 by the American Association for the Advancement of Science, publishing translational research that bridges preclinical studies and clinical applications, with print ISSN 1946-6234 and online ISSN 1946-6242, and its 2025 Journal Impact Factor is 15.6（Science Translational Medicine）是（American Association for the Advancement of Science）于 2009 年 10 月创办的同行评审周刊，发表连接临床前研究与临床应用的转化研究，印刷 ISSN 为 1946-6234，在线 ISSN 为 1946-6242，2025 年影响因子为 15.6。

Scope

• It is an interdisciplinary journal publishing translational research with impact for human health that fills the knowledge gaps between preclinical studies and clinical applications作为跨学科期刊，发表对人类健康有影响的转化研究，填补临床前研究与临床应用之间的知识空白。
• The journal spans all areas of medicine and works to turn basic biological discoveries into medical advances覆盖医学各领域，致力于把基础生物学发现转化为医学进步。
• It carries original research articles, in-depth reviews and commentary刊载原创研究论文、深度综述与评论。
• Its tagline Integrating Medicine and Science reflects a bench-to-bedside focus刊物标语为（Integrating Medicine and Science），体现从实验室到病床的取向。
• Recent issues contain research articles, editorials and prize essays such as the AAAS Martin and Rose Wachtel Cancer Research Award essay近期各期包含研究论文、社论与获奖论文，如（AAAS Martin and Rose Wachtel Cancer Research Award）获奖论文。
• Recent papers report work on Alzheimer disease, uterine cancer and metabolic ageing近期论文报道阿尔茨海默病、子宫癌与代谢老化等方向的研究。

History

• It was launched in October 2009 by AAAS as a journal aimed at advancing clinical medicine, with Katrina L. Kelner as founding Editor该刊于 2009 年 10 月由（AAAS）创办，以推进临床医学为目标，创刊编辑为（Katrina L. Kelner）。^[1]
• Its chief scientific advisers are Elazer R. Edelman of MIT and Garret A. FitzGerald of the University of Pennsylvania首席科学顾问为（MIT）的（Elazer R. Edelman）与（University of Pennsylvania）的（Garret A. FitzGerald）。
• It is published weekly except for the last week in December by AAAS of Washington, DC该刊由位于华盛顿特区的（AAAS）按周刊出版，12 月最后一周休刊。
• The journal marked its 10th anniversary in 2019 with the Science Transforming Medicine Focus series2019 年该刊以（Science Transforming Medicine）焦点系列纪念创刊十周年。^[2]
• It had reached volume 18 by 2026, issuing about 50 issues a year至 2026 年已出至第 18 卷，每年出版约 50 期。
• Its Journal Impact Factor moved from 17.956 in 2021 to 19.319 in 2022, then 14.6 in 2024 and 15.6 in 2025影响因子由 2021 年的 17.956 升至 2022 年的 19.319，2024 年为 14.6，2025 年为 15.6。
• In the 2025 Journal Citation Reports it is Q1 in Medicine, Research and Experimental, ranking fifth of 191 titles in SCIE在 2025 年（JCR）中位列医学研究与实验类别 Q1，在（SCIE）的 191 种期刊中排名第 5。

Editors

• The Editor of Science Translational Medicine is Orla Smith（Science Translational Medicine）现任编辑为（Orla Smith）。
• Katrina L. Kelner was the journal's founding Editor and later wrote about its first five years（Katrina L. Kelner）为该刊创刊编辑，其后撰文回顾该刊最初五年。^[3]
• A staff editorial team at AAAS handles research manuscripts由（AAAS）的专职编辑团队处理研究稿件。
• An international Scientific Advisory Board advises the journal, with members such as Robert Langer of MIT and Carl H. June of the University of Pennsylvania该刊设有国际科学顾问委员会，成员包括（MIT）的（Robert Langer）与（University of Pennsylvania）的（Carl H. June）。
• Valda Vinson, Executive Editor of the Science journals, oversees the title alongside Science, Science Signaling and Science Immunology（Science）系列期刊执行编辑（Valda Vinson）分管该刊与（Science）、（Science Signaling）及（Science Immunology）。